Edition:
United Kingdom

Joincare Pharmaceutical Group Industry Co Ltd (600380.SS)

600380.SS on Shanghai Stock Exchange

11.39CNY
14 Feb 2018
Change (% chg)

¥0.00 (+0.00%)
Prev Close
¥11.39
Open
¥11.46
Day's High
¥11.48
Day's Low
¥11.34
Volume
9,831,975
Avg. Vol
37,707,968
52-wk High
¥13.99
52-wk Low
¥8.10

Latest Key Developments (Source: Significant Developments)

Joincare Pharmaceutical Expects 2017 Net Profit To Rise 362.5-383.9 Percent Y/Y
Friday, 12 Jan 2018 

Jan 12 (Reuters) - Joincare Pharmaceutical Group Industry Co Ltd <600380.SS>::SAYS IT EXPECTS 2017 NET PROFIT TO RISE 362.5-383.9 PERCENT Y/Y VERSUS 451 MILLION YUAN ($69.67 million) YEAR AGO.  Full Article

Livzon Pharmaceutical Group unit receives approval for drug clinical trial
Tuesday, 2 Jan 2018 

Jan 2 (Reuters) - Livzon Pharmaceutical Group Inc <000513.SZ>:Says Zhuhai-based biotechnology unit received drug clinical trial approval for drug named Recombinant Human anti-RANKL Monoclonal Antibody Solution for Injection.  Full Article

Livzon Pharmaceutical Group unit receives approval for drug clinical trial
Friday, 3 Nov 2017 

Nov 3 (Reuters) - Livzon Pharmaceutical Group Inc <000513.SZ>:Says its unit received drug clinical trial approval for Recombinant Humanized anti-PD-1 Monoclonal Antibody for Injection .  Full Article

Joincare Pharmaceutical Group Industry unit receives approval for drug clinical trial
Friday, 3 Nov 2017 

Nov 3(Reuters) - Joincare Pharmaceutical Group Industry Co Ltd <600380.SS>:Says co's Zhuhai-based biotechnology unit received approval for drug clinical trial, regarding recombinant humanized anti-PD-1 monoclonal antibody for injection, from China Food and Drug Administration.  Full Article

Joincare Pharmaceutical Group Industry sees FY 2017 net profit up 337.2 pct to 370.3 pct
Friday, 27 Oct 2017 

Oct 27 (Reuters) - Joincare Pharmaceutical Group Industry Co Ltd <600380.SS>:Says it sees net profit for FY 2017 to increase 337.2 percent to 370.3 percent, or to be 1.97 billion yuan to 2.12 billion yuan.Says the net profit of FY 2016 was 451.4 million yuan.Comments that sale of unit as main reason for the forecast .  Full Article

Joincare Pharmaceutical Group's 9-month net profit up 441.9 pct y/y
Thursday, 26 Oct 2017 

Oct 26 (Reuters) - Joincare Pharmaceutical Group Industry Co Ltd <600380.SS>:Says 9-month net profit up 441.9 percent y/y.  Full Article

Joincare Pharmaceutical Group Industry units get drug clinical trial approval for Tobramycin Inhalation Solution
Wednesday, 25 Oct 2017 

Oct 25 (Reuters) - Joincare Pharmaceutical Group Industry Co Ltd <600380.SS> ::Says its units and partners get drug clinical trial approval for Tobramycin Inhalation Solution.  Full Article

Joincare Pharmaceutical expects 9-month net profit to rise to 2.0-2.1 bln yuan
Friday, 13 Oct 2017 

Oct 13 (Reuters) - Joincare Pharmaceutical Group Industry Co Ltd <600380.SS>:Says it expects 9-month net profit to rise to 2.0-2.1 billion yuan from 373.8 million yuan ($56.76 million) year ago.  Full Article

Livzon Pharmaceutical Group units receive approval for drug clinical trials
Monday, 18 Sep 2017 

Sept 18 (Reuters) - Livzon Pharmaceutical Group Inc <000513.SZ>:* Says its units received drug clinical trials approval for drug, Triptorelin Acetate Microspheres for Injection.  Full Article

Joincare Pharmaceutical Group Industry issues 600 mln yuan worth of commercial paper
Monday, 8 Aug 2016 

Joincare Pharmaceutical Group Industry Co., Ltd. <600380.SS>: Says it issues first tranche of 2016 super short-term financing bills worth 600 million yuan . Says the bills with a term of 270 days and an interest rate of 2.8 percent .Says the maturity date of May 1, 2017.  Full Article

CORRECTED-BRIEF-Livzon Pharmaceutical Unit's JV Livzon Biologics' Capital Will Be Boosted By 600 Mln Yuan (Feb 7)

* SAYS CAPITAL AT UNIT'S JV LIVZON BIOLOGICS WILL BE BOOSTED BY 600 MILLION YUAN ($94.94 million) Source text in Chinese: http://bit.ly/2nMWH27 Further company coverage: ($1 = 6.3201 Chinese yuan renminbi) (Reporting by Hong Kong newsroom)